Is China the next medical-tourism hub, or is social media exaggerating the trend?

TikTok videos showing fast, inexpensive Chinese hospital care have created the impression of a medical-tourism boom. Foreign creators have documented MRIs, endoscopy, pediatric visits, dental treatment, acupuncture, and checkups—often contrasting a short Chinese wait with a long or expensive experience at home.

China may become a significant medical-travel destination. The evidence does not show that it already is one at mass scale.

What is clearly changing

More foreigners can enter easily

China recorded 30.08 million visa-free entries by foreign nationals in 2025, a 49.5% year-over-year increase, according to the National Immigration Administration. That does not mean 30 million medical tourists. It does mean a much larger pool of visitors can add a checkup, dental visit, or specialist consultation to a trip.

Social media has exposed a genuine contrast

A Chinese medical-industry investigation reported that American creator Aisha's MRI video exceeded 150,000 views and that British creator Amie published ten China-care videos receiving more than 100,000 views each (Medical Community/Sohu).

The format is powerful: show the clock, reveal the bill, and compare it with the United States, United Kingdom, or Canada. Routine diagnostics become travel content.

Cities are building international-patient infrastructure

Shanghai designated 13 public hospitals as international medical-tourism pilots. Its broader policy agenda includes foreign-language booking, passport-friendly registration, multilingual documents, international payments, direct insurance settlement, and collaboration with travel agencies and hotels (Shanghai government).

Beijing expanded multilingual hospital directories, English booking through the Jingtong mini-program, and staff training. Yiwu Central Hospital added doctor-reviewed English reports and direct-billing relationships with 22 global insurers.

These investments would be unnecessary if the service gaps were imaginary.

Why “foreigners are flooding China” is premature

No reliable national dataset separates:

• foreigners living in China;
• tourists who become sick unexpectedly;
• business travelers adding a checkup;
• repeat outpatient visits;
• people who traveled primarily for treatment.

City figures for “overseas patient visits” can count all these categories and may count the same patient several times.

Boao Lecheng in Hainan reported 413,700 medical tourists in 2024, up 36.8%. That figure includes domestic medical travelers and is not an international-patient count (Hainan government).

A Shanghai medical-escort operator told a local newspaper that foreign business was increasing but still not large enough for most escorts to rely on full time. That is more consistent with a growing niche than a national rush.

Where China has a real competitive advantage

China is strongest where it can offer one or more of the following:

• rapid imaging and endoscopy;
• comparatively low self-pay prices;
• high-volume public-hospital specialists;
• dense urban diagnostic infrastructure;
• selected advanced treatments or devices;
• TCM and rehabilitation programs;
• care added to an existing trip.

For complex disease, the advantage is specialty-specific. A Polish family found a Shanghai pediatric cancer team through PubMed; Malaysian pediatric liver-transplant referrals grew through clinical and patient networks; and foreign patients have sought selected cell therapies unavailable at home. These pathways depend on evidence and trusted referral relationships, not viral marketing.

Where China still trails established destinations

Thailand, Singapore, South Korea, India, and Malaysia have spent years building international medical brands, English-language service, packaged pricing, hospital accreditation, and tourism logistics.

China's clinical capacity can be excellent, but the surrounding journey remains fragmented:

• hospital selection is difficult;
• online booking may reject passports;
• English service is inconsistent;
• direct billing varies by insurer and department;
• records may not be portable;
• post-return follow-up is weak;
• visa treatment routes can be confusing;
• independent outcome data are limited.

The best doctor and the easiest international service may not be in the same institution.

What will determine the next stage

China will become a stronger medical-travel destination if providers can build five forms of trust:

1. transparent doctor and program selection;
2. clinically appropriate, not volume-driven, testing;
3. itemized pricing and disclosed referral fees;
4. bilingual records and insurer-ready documentation;
5. shared follow-up with clinicians in the patient's home country.

The bottom line

Social media is exaggerating the scale but correctly identifying the underlying opportunity. China is not yet a frictionless global medical-tourism hub. It is a large clinical system with pockets of exceptional capability, increasingly accessible travel, and a missing international service layer.

If that layer matures, the market could grow substantially. Until then, the most realistic customer is not someone booking a generic “medical vacation.” It is someone with a specific access problem, a specific doctor or test in mind, and a strong need for help connecting the pieces.